{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:27:02Z","timestamp":1747171622638,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.thromres.2015.08.028","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T17:18:02Z","timestamp":1441646282000},"page":"843-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic immune thrombocytopenia and semaphorin 5A"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-9472","authenticated-orcid":false,"given":"Shosaku","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.08.028_bb0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2015.08.028_bb0010","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokines levels in acute and chronic autoimmune thrombocytopenic purpura: relationhip to platelet phenotype and antiplatelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.08.028_bb0015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI4238","article-title":"Autoreactive T cells to platelet GPIIb\u2013IIIa in immune thrombocytopenic purpura: role in production of antiplatelet autoantibody","volume":"102","author":"Kuwana","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2015.08.028_bb0020","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood.V91.10.3616","article-title":"Clincal significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura","volume":"91","author":"Nomura","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.08.028_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V98.1.130","article-title":"Immunodominant epitopes on glycoprotein IIb\u2013IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura","volume":"98","author":"Kuwana","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.08.028_bb0030","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Mechanisms of desease: interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2015.08.028_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2014.03.002","article-title":"High-dose dexamethasone modulates serum cytokine profile in patients with primary immune thrombocytopenia","volume":"160","author":"Zhan","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.thromres.2015.08.028_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.imlet.2013.08.006","article-title":"Correction of abnormal T cell subsets by high-dose dexamathasone in patients with chronic idiopathic thrombocytopenic purpura","volume":"154","author":"Li","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.thromres.2015.08.028_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pbc.22984","article-title":"Reduced expression of transforming growth factor-\u03b21 and correlated elevation of interleukin-17 and interferon-\u03b3 in pediatric patients with chronic primary immune thrombocytopenia (ITP)","volume":"57","author":"Wang","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2015.08.028_bb0050","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2008-03-148288","article-title":"De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25\u2212 cells in patients with idiopathic thrombocytopenic purpura","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.08.028_bb0055","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2010-04-281717","article-title":"Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents","volume":"116","author":"Bao","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.08.028_bb0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.thromres.2012.06.002","article-title":"TGF1 and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP","volume":"130","author":"Fujita","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2015.08.028_bb0065","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0092-8674(93)90625-Z","article-title":"The semaphoring genes encode a family of transmembrane and secreted growth cone guidance molecules","volume":"75","author":"Kolodkin","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2015.08.028_bb0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuron.2011.06.009","article-title":"Class 5 transmembrane semaphorins control selective mammalian retin al lamination and function","volume":"71","author":"Matsuoka","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.thromres.2015.08.028_bb0075","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.38425","article-title":"Secreted semaphoring 5A activates immune effector cells and is a biomarker for rheumatoid arthritis","volume":"66","author":"Gras","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.thromres.2015.08.028_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.thromres.2015.07.032","article-title":"Elevated semaphoring 5A correlated with Th1 polarization in patients with chronic immune thrombocytopenia","volume":"136","author":"Lyu","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2015.08.028_bb0085","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarrized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815301110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815301110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T02:40:48Z","timestamp":1599532848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815301110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0049384815301110"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.08.028","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic immune thrombocytopenia and semaphorin 5A","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}